Citation: J. Balldin, WHAT ARE THE EVIDENCES FOR THE USE OF SSRI AND OTHER ANTIDEPRESSANTS IN THE TREATMENT OF SUBSTANCE-ABUSE DISORDERS, Nordic journal of psychiatry, 52, 1998, pp. 297-297
Authors:
BENDZ H
AURELL M
BALLDIN J
MATHE AA
SJODIN I
Citation: H. Bendz et al., KIDNEY DAMAGE IN LONG-TERM LITHIUM PATIENTS - A CROSS-SECTIONAL STUDYOF PATIENTS WITH 15 YEARS OR MORE ON LITHIUM, Nephrology, dialysis, transplantation, 9(9), 1994, pp. 1250-1254
Authors:
BALLDIN J
BERGGREN U
LINDSTEDT G
ORELAND L
Citation: J. Balldin et al., ALCOHOLICS WITH REDUCED DOPAMINE D-2 RECEPTOR FUNCTION POSSESS NORMALPLATELET MONOAMINE-OXIDASE ACTIVITY, Alcohol and alcoholism, 29(6), 1994, pp. 659-661
Authors:
BALLDIN J
BERGGREN U
BOKSTROM K
ERIKSSON M
GOTTFRIES CG
KARLSSON I
WALINDER J
Citation: J. Balldin et al., 6-MONTH OPEN TRIAL WITH ZIMELIDINE IN ALCOHOL-DEPENDENT PATIENTS - REDUCTION IN DAYS OF ALCOHOL INTAKE, Drug and alcohol dependence, 35(3), 1994, pp. 245-248
Authors:
BALLDIN J
BERGGREN U
ENGEL J
ERIKSSON M
HARD E
SODERPALM B
Citation: J. Balldin et al., EFFECT OF CITALOPRAM ON ALCOHOL INTAKE IN HEAVY DRINKERS, Alcoholism, clinical and experimental research, 18(5), 1994, pp. 1133-1136
Citation: J. Balldin et al., NEUROENDOCRINE EVIDENCE FOR REDUCED SEROTONERGIC NEUROTRANSMISSION DURING HEAVY DRINKING, Alcoholism, clinical and experimental research, 18(4), 1994, pp. 822-825
Authors:
BALLDIN J
BERGGREN U
LINDSTEDT G
SUNDKLER A
Citation: J. Balldin et al., FURTHER NEUROENDOCRINE EVIDENCE FOR REDUCED D(2)-DOPAMINE RECEPTOR FUNCTION IN ALCOHOLISM, Drug and alcohol dependence, 32(2), 1993, pp. 159-162